Literature DB >> 16187871

Acute cortisol elevations cause heightened arousal ratings of objectively nonarousing stimuli.

Heather C Abercrombie1, Ned H Kalin, Richard J Davidson.   

Abstract

To test the effects of cortisol on affective experience, the authors orally administered a placebo, 20 mg cortisol, or 40 mg cortisol to 85 men. Participants' affective responses to negative and neutral stimuli were measured. Self-reported affective state was also assessed. Participants in the 40-mg group (showing extreme cortisol elevations within the physiological range) rated neutral stimuli as more highly arousing than did participants in the placebo and 20-mg groups. Furthermore, within the 20-mg group, individuals with higher cortisol elevations made higher arousal ratings of neutral stimuli. However, cortisol was unrelated to self-reported affective state. Thus, findings indicate that acute cortisol elevations cause heightened arousal in response to objectively nonarousing stimuli, in the absence of effects on mood. ((c) 2005 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187871     DOI: 10.1037/1528-3542.5.3.354

Source DB:  PubMed          Journal:  Emotion        ISSN: 1528-3542


  15 in total

1.  Relation of intimate partner violence to salivary cortisol among couples expecting a first child.

Authors:  Mark E Feinberg; Damon E Jones; Douglas A Granger; Daniel Bontempo
Journal:  Aggress Behav       Date:  2011-08-09       Impact factor: 2.917

2.  Postreactivation glucocorticoids impair recall of established fear memory.

Authors:  Wen-Hui Cai; Jacqueline Blundell; Jie Han; Robert W Greene; Craig M Powell
Journal:  J Neurosci       Date:  2006-09-13       Impact factor: 6.167

3.  Melatonin increases reactive aggression in humans.

Authors:  Jinting Liu; Ru Zhong; Wei Xiong; Haibo Liu; Christoph Eisenegger; Xiaolin Zhou
Journal:  Psychopharmacology (Berl)       Date:  2017-07-21       Impact factor: 4.530

4.  The effect of cortisol on emotional responses depends on order of cortisol and placebo administration in a within-subject design.

Authors:  Michelle M Wirth; Sean M Scherer; Roxanne M Hoks; Heather C Abercrombie
Journal:  Psychoneuroendocrinology       Date:  2011-01-13       Impact factor: 4.905

5.  Glucocorticoids reduce phobic fear in humans.

Authors:  Leila M Soravia; Markus Heinrichs; Amanda Aerni; Caroline Maroni; Gustav Schelling; Ulrike Ehlert; Benno Roozendaal; Dominique J-F de Quervain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Predicting developmental changes in internalizing symptoms: examining the interplay between parenting and neuroendocrine stress reactivity.

Authors:  Kate R Kuhlman; Sheryl L Olson; Nestor L Lopez-Duran
Journal:  Dev Psychobiol       Date:  2013-09-06       Impact factor: 3.038

Review 7.  Sex differences in salivary cortisol in response to acute stressors among healthy participants, in recreational or pathological gamblers, and in those with posttraumatic stress disorder.

Authors:  Jason J Paris; Christine Franco; Ruthlyn Sodano; Brian Freidenberg; Elana Gordis; Drew A Anderson; John P Forsyth; Edelgard Wulfert; Cheryl A Frye
Journal:  Horm Behav       Date:  2009-06-16       Impact factor: 3.587

8.  Acute exposure to stress improves performance in trace eyeblink conditioning and spatial learning tasks in healthy men.

Authors:  Roman Duncko; Brian Cornwell; Lihong Cui; Kathleen R Merikangas; Christian Grillon
Journal:  Learn Mem       Date:  2007-05-01       Impact factor: 2.460

Review 9.  Testosterone, Cortisol and Financial Risk-Taking.

Authors:  Joe Herbert
Journal:  Front Behav Neurosci       Date:  2018-05-16       Impact factor: 3.558

10.  Childhood Emotional Abuse Moderates Associations Among Corticomotor White Matter Structure and Stress Neuromodulators in Women With and Without Depression.

Authors:  Carlton P Frost; M Elizabeth Meyerand; Rasmus M Birn; Roxanne M Hoks; Erin C Walsh; Heather C Abercrombie
Journal:  Front Neurosci       Date:  2018-04-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.